Find Clinical Drug Pipeline Developments & Deals for Paricalcitol

Paricalcitol
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check all USDMF suppliers

Contact Us
PharmaScopic.com

Paricalcitol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 11 USDMF, 6 KDMF, 6 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

FINISHED DOSAGE FORMULATIONS

128 FDF Dossiers, 58 FDA Orange Book, 50 Europe, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 1MCG, CAPSULE;ORAL - 2MCG, CAPSULE;ORAL - 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 9 DKSH, 1 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 11 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 6 Gangwal Chemicals, 3 Ideal Cures, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 1 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 13 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 22 Solubilizers, 19 Topical, 18 Film Formers & Plasticizers, 16 Controlled & Modified Release, 16 Parenteral, 14 Thickeners and Stabilizers, 12 Fillers, Diluents & Binders, 9 Empty Capsules, 8 Emulsifying Agents, 8 Taste Masking, 7 Granulation, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Direct Compression, 3 Chewable & Orodispersible Aids, 2 Lubricants & Glidants, 2 Co-Processed Excipients, 1 Soft Gelatin, 1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

14 News #PharmaBuzz

14 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 44 Regulatory FDF Prices

MARKET PLACE

7 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 Others

2 Others

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Paricalcitol

Therapeutic Area : Nephrology

Study Phase : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperpara...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 22, 2019

Lead Product(s) : Paricalcitol

Therapeutic Area : Nephrology

Highest Development Status : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

Dr. Reddy's Laboratories

India

CPhI WW Frankfurt

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Lead Product(s) : Paricalcitol

Therapeutic Area : Undisclosed

Study Phase : Phase I

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

December 23, 2014

Lead Product(s) : Paricalcitol

Therapeutic Area : Undisclosed

Highest Development Status : Phase I

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Dr Reddy Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Paricalcitol

Therapeutic Area : Endocrinology

Study Phase : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumpti...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

January 10, 2012

Lead Product(s) : Paricalcitol

Therapeutic Area : Endocrinology

Highest Development Status : Phase IV

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Paricalcitol

Therapeutic Area : Nephrology

Study Phase : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chron...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 27, 2011

Lead Product(s) : Paricalcitol

Therapeutic Area : Nephrology

Highest Development Status : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

AbbVie Inc

U.S.A

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Paricalcitol

Therapeutic Area : Endocrinology

Study Phase : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chro...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

April 26, 2011

Lead Product(s) : Paricalcitol

Therapeutic Area : Endocrinology

Highest Development Status : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Abbvie Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

06

Chengdu Suncadia Medicine

Country

Peptide Process CMC

Not Confirmed

07

University of Hong Kong

Country

Peptide Process CMC

Not Confirmed

08

Effice Servicios Para la Investigacion

Country

Peptide Process CMC

Not Confirmed

09

Azienda Ospedaliera Sant'Anna

Country

Peptide Process CMC

Not Confirmed

10

Fundación Senefro

Country

Peptide Process CMC

Not Confirmed

1
2